Lexaria Bioscience (LEXX) Q3 2026 Earnings

13JulConfirmed
Q4 2025
Q1 2026
Q2 2026
Q3 2026
-1.2
-0.82
-0.45
-0.07

Details

Expected EPS
-0.9
Actual EPS
-1.2
Surprise EPS
-0.3
Surprise Percent
+33.33%

Description

Lexaria Bioscience (LEXX) has reported earnings of -1.2 per share for Q3 2026.

0 Comments

Share your thoughts